E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
GSK’s newly approved Shingrix prefilled syringe is ready to use, making administration simpler and more convenient for healthcare professionals.
imphoenix82
GSK’s investigational mRNA seasonal flu vaccine is designed to target both haemagglutinin (HA) and neuraminidase (NA), the primary surface antigens that cause the flu virus to bind and spread.
imphoenix82
If approved, Jemperli could eliminate the need for chemotherapy, radiation, and surgery for some patients with dMMR/MSI-H locally advanced rectal cancer, said GSK.
imphoenix82
The approval marks the first global approval for bepirovirsen, and makes Hibsago the first and only treatment approved in Japan as a functional cure for chronic hepatitis B.
imphoenix82
GSK has announced plans to establish a major new global research and development (R&D) centre in Cambridge, UK, with plans to vacate its existing R&D site in Stevenage, Hertfordshire, by 2029. The new 300,000-square-foot R&D facility on the Cambridge Biomedical Campus, one of Europe’s largest biomedical research hubs, will become home to GSK’s UK R&D […]
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
